Literature DB >> 27344298

Is procalcitonin a useful biomarker for the risk stratification of facial cellulitis?

Chloé Bertolus1, Thomas Schouman2, Adeline Aubry3, Pierre Hausfater4.   

Abstract

BACKGROUND: Facial cellulitis is an infectious disease that may require emergency surgical drainage based on clinical assessment. To date, no biological marker has been reported to be useful for risk stratification. Procalcitonin (PCT) is a diagnostic and prognostic sepsis biomarker. We aimed to study the usefulness of PCT dosage for the risk-stratification of facial cellulitis. PATIENTS AND METHODS: This was a monocentric prospective study conducted in a referral center for maxillofacial emergencies. Patients with a diagnosis of facial cellulitis were included and underwent a PCT measurement at admission. The main criterion was the requirement for surgical drainage.
RESULTS: Seventy consecutive patients were included in a 7-months period, mean age 35 ± 14 years. Surgical drainage was required for 48 patients (68%). Serum PCT concentrations were strictly negative in most patients (median [IQR]: 0.05 μg/L [0.05; 0.10]). Only 6 patients (9%) had PCT values above the clinical threshold of 0.25 μg/L. At a threshold of 0.1 μg/L, PCT was 30% sensitive and 100% specific for surgical drainage requirement.
CONCLUSION: PCT level usually remains in a low range in facial cellulitis and seems to have a limited added value for risk stratification.
Copyright © 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Emergency department; Facial cellulitis; Procalcitonin; Severity assessment

Mesh:

Substances:

Year:  2016        PMID: 27344298     DOI: 10.1016/j.jcms.2016.05.023

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  2 in total

1.  Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study.

Authors:  Thomas Waterfield; Julie-Ann Maney; Martin Hanna; Derek Fairley; Michael D Shields
Journal:  BMC Pediatr       Date:  2018-12-12       Impact factor: 2.125

2.  Clinical utility of procalcitonin in severe odontogenic maxillofacial infection.

Authors:  Ji-Kwan Kim; Jae-Hoon Lee
Journal:  Maxillofac Plast Reconstr Surg       Date:  2021-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.